| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10918947 | Radiotherapy and Oncology | 2012 | 7 Pages |
Abstract
IMPTrobust proved advantageous in terms of lung exposure and possible dose escalation while being also markedly robust. However, motion during delivery of a field remains a major problem of IMPTrobust to be mitigated by high scanning speed and variable spot size.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Martin Stuschke, Andreas Kaiser, Christoph Pöttgen, Wolfgang Lübcke, Jonathan Farr,